← All stories
Markets 1 sources

Eli Lilly stock stalls near $1,140 as Foundayo grabs 30% of new obesity-drug patients

Covered by 1 source · 1 article

Eli Lilly stock presents conflicting signals across timeframes. The daily chart shows cooling, while the hourly hints at stabilization. Meanwhile, Berenberg upgraded LLY on obesity drug strength, as Foundayo captured over 30% of new U.S. or…

Covered by

All coverage

Eli Lilly stock stalls near $1,140 as Foundayo grabs 30% of new obesity-drug patients
Cryptonomist 3h ago

Eli Lilly stock stalls near $1,140 as Foundayo grabs 30% of new obesity-drug patients

Eli Lilly stock presents conflicting signals across timeframes. The daily chart shows cooling, while the hourly hints at stabilization. Meanwhile, Berenberg upgraded LLY on obesity drug strength, as Foundayo captured over 30% of new U.S. or…

More top stories